Condition: Colonic Neoplasms Malignant · Cecal Neoplasms · Sponsor: Moscow Clinical Scientific Center
The purpose of this study is to determine the clinical efficacy, safety, and oncologic outcomes of ileocecal resection (ICR) with D3 lymphadenectomy compared to standard right hemicolectomy(RHC) for cecal cancer.
This description comes directly from the study's public registry record.
Igor Matveev · +7(916)182-17-46 · i.matveev@mknc.ru
Mikhail Danilov · +7(967) 136-76-87 · m.danilov@mknc.ru
Always discuss trial participation with your own doctor first.
| Moscow Clinical Scientific Center | Moscow, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06121089